Endoscopic and chromoendoscopic atlas featuring dysplastic lesions in surveillance colonoscopy for patients with long-standing ulcerative colitis

Inflammatory Bowel Diseases

Volumn 14, Issue 2, 2008, Pages 259-264

  Matsumoto, Takayuki ^a   Iwao, Yasushi ^b   Igarashi, Masahiro ^c   Watanabe, Kenji ^d   Otsuka, Kazuo ^e   Watanabe, Toshiaki ^f   Iizuka, Bunei ^g   Hida, Nobuyuki ^a   Sada, Miwa ^h   Chiba, Toshimi ⁱ   Kudo, Shin Ei ^e   Oshitani, Nobuhide ^d   Nagawa, Hirokazu ^j   Ajioka, Yoichi ^k   Hibi, Toshifumi ^b  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c CANCER INSTITUTE HOSPITAL   (Japan)

^d OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e SHOWA UNIVERSITY   (Japan)

^f TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^h KITASATO UNIVERSITY HOSPITAL   (Japan)

ⁱ IWATE MEDICAL UNIVERSITY   (Japan)

^j UNIVERSITY OF TOKYO   (Japan)

^k NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

more..

Author keywords

Cancer surveillance; Chromoendoscopy; Dysplasia; Endoscopy; Ulcerative colitis

Indexed keywords

CANCER DIAGNOSIS; CANCER PATIENT; CHROMOENDOSCOPY; COLON ADENOCARCINOMA; COLON BIOPSY; COLON MUCOSA; COLONOSCOPY; CYTOPATHOLOGY; DIAGNOSTIC APPROACH ROUTE; DIGESTIVE SYSTEM INJURY; GASTROINTESTINAL DYSPLASIA; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MUCOSA CELL; PATHOLOGICAL ANATOMY; PRECANCER; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS;

ATLASES AS TOPIC; COLITIS, ULCERATIVE; COLONIC NEOPLASMS; COLONOSCOPY; COLORING AGENTS; HUMANS; MASS SCREENING; PRECANCEROUS CONDITIONS;

EID: 39649106598     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20267     Document Type: Review

References (26)

1. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526-535.
2. Greenstein AJ, Sachar DB, Smith H, et al. Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology. 1979;77:290-294.
3. Karlen P, Kornfeld D, Brostrom O, et al. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut. 1998;42:711-714.
4. Velayos FS, Lftus EV, Jess T, et al. Predictive and Protective factors associated with colorectal cancer in ulcerative colitis: a case-control study. Gastroenterology. 2006;130:1941-1949.
5. Ekbom A. Motion-colonoscopic surveillance is more cost effective than colectomy in patients with ulcerative colitis: arguments against the motion. Can J Gastroenterol. 2003;17:122-124.
6. Winawer S, Fletcher R, Rex D, et al; Gastrointestinal Consortium Panel. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology. 2003;124:544-560
7. Eaden J, Mayberry JF; British Society for Gastroenterology; Association of Coloproctology for Great Britain and Ireland. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut. 2002;51(Suppl V):v10-v12.
8. Hibi T, Ogata H. Novel pathophysiological concepts of inflammatory bowel disease. J Gastroenterol. 2006;41:10-16
9. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983;14:931-968
10. Kiesslich R, Fritsch J, Holtmann M, et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology. 2003;124:880-888.
11. Rutter MD, Saunders BP, Schofield G, Forbes A, Price AB, Talbot IC. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut. 2004;53:256-260.
12. Kudo SE, Kashida H. Flat and depressed lesions of the colorectum. Clin Gastroenterol Hepatol. 2005;3(Suppl 1):S33-S36.
13. Kiesslich R, von Bergh M, Hahn M, et al. Chromoendoscopy with indigocarmine improves the detection of adenomatous and nonadenomatous lesions in the colon. Endoscopy. 2001;33:1001-1006.
14. Rutter MD, Saunders BP, Wilkinson KH, et al. Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc. 2004; 60:334-339.
15. Lashner BA, Bauer WM, Rybicki LA, et al. Abnormal p53 immunohistochemistry is associated with an increased colorectal cancer-related mortality in patients with ulcerative colitis. Am J Gastroenterol. 2003; 98:1423-1427.
16. Kiesslich R, Rutter MD, Saunders BP, et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut. 2004;53:256-260.
17. Sada M, Igarashi M, Yoshizawa S, et al. Dye spraying and magnifying endoscopy for dysplasia and cancer surveillance in ulcerative colitis. Dis Colon Rectum. 2004;47:1816-1823.
18. Hata K, Watanabe T, Motoi T, et al. Pitfalls of pit pattern diagnosis in ulcerative colitis-associated dysplasia. Gastroenterology. 2004; 126:374-376.
19. Hata K, Watanabe T, Kazama S, et al. Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population. Br J Cancer. 2003;89:1232-1236.
20. Hata K, Watanabe T, Shinozaki M, et al. To dye or not to dye? That is beyond question! Optimizing surveillance colonoscopy is indispensable for detecting dysplasia in ulcerative colitis. Gut. 2004;53: 1722.
21. Matsumoto T, Nakamura S, Jo Y, et al. Chromoscopy might improve diagnostic accuracy in cancer surveillance for ulcerative colitis. Am J Gastroenterol. 2003;98:1827-1833.
22. Kiesslich R, Neurath MF. Chromoendoscopy and other novel imaging techniques. Clin North Am. 2006;35:605-619.
23. Dekker E, Fockens P. New imaging techniques at colonoscopy: tissue spectroscopy and narrow band imaging. Gastrointest Endosc Clin N Am. 2005;15:703-714
24. East JE, Suzuki N, von Herbay A, et al. Narrow band imaging with magnification for dysplasia detection and pit pattern assessment in ulcerative colitis surveillance: a case with multiple dysplasia associated lesions or masses. Gut. 2006;55:1432-1435.
25. Kara MA, Bergman JJ. Autofluorescence imaging and narrow-band imaging for the detection of early neoplasia in patients with Barrett's esophagus. Endoscopy. 2006;38:627-631.
26. Kiesslich R, Neurath MF. Endoscopic confocal imaging. Clin Gastroenterol Hepatol. 2005;3(Suppl 1):S58-S60.